Dagrocorat
Dagrocorat
Dagrocorat (pronounced: /dæɡroʊkɔːræt/) is a novel nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it specifically targets and inhibits the COX-2 enzyme, reducing the production of prostaglandins that cause inflammation and pain.
Etymology
The term "Dagrocorat" is a modern coinage, derived from the pharmaceutical nomenclature. The exact etymology is unknown, but it is likely that the name was created by the pharmaceutical company that developed the drug.
Usage
Dagrocorat is used to relieve symptoms of osteoarthritis, including pain and inflammation. It is taken orally, usually once or twice a day. Like other NSAIDs, Dagrocorat can cause side effects, including stomach upset, heartburn, and nausea. It should be used with caution in patients with a history of gastrointestinal problems or cardiovascular disease.
Related Terms
- Nonsteroidal anti-inflammatory drug (NSAID)
- Osteoarthritis
- Cyclooxygenase-2 (COX-2)
- Prostaglandins
- Gastrointestinal
- Cardiovascular disease
External links
- Medical encyclopedia article on Dagrocorat
- Wikipedia's article - Dagrocorat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski